Aligos Therapeutics (ALGS) Research & Development (2019 - 2026)
Aligos Therapeutics (ALGS) recorded Research & Development of $24.05 million in Q2 2026, up 72.1% from $13.98 million a year earlier and up 3.0% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Research & Development (2019 - 2026) Analysis & Trends
On a TTM basis, Aligos Therapeutics' Research & Development came in at $88.38 million as of Jun 30, 2026, up 44.2% year-over-year; for FY2025, it was $69.45 million, down 1.2% from FY2024.
- Annual Research & Development has declined for four straight years, with a five-year compound annual growth rate of -2.8% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $70.27 million in FY2024 (-3.8%), $73.04 million in FY2023 (-14.1%), $85.08 million in FY2022 (-18.3%) and $104.15 million in FY2021 (+30.4%).
- The Q2 2026 figure is the highest quarterly Research & Development since Q1 2022.
- On a year-over-year basis, Research & Development has increased for four consecutive quarters, with growth averaging 14.3% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 72.1% in Q2 2026, against a decline of 42.7% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $23.35 million (Q1 2026), $17.04 million (Q4 2025) and $23.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Aligos Therapeutics | 52.47 Mn | -275.94 Mn | - | 24.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.05 Mn |
| Mar 31, 2026 | 23.35 Mn |
| Dec 31, 2025 | 17.04 Mn |
| Sep 30, 2025 | 23.94 Mn |
| Jun 30, 2025 | 13.98 Mn |
| Mar 31, 2025 | 14.50 Mn |
| Dec 31, 2024 | 16.03 Mn |
| Sep 30, 2024 | 16.77 Mn |
| Jun 30, 2024 | 21.10 Mn |
| Mar 31, 2024 | 16.37 Mn |
| Dec 31, 2023 | 22.26 Mn |
| Sep 30, 2023 | 15.87 Mn |
| Jun 30, 2023 | 16.78 Mn |
| Mar 31, 2023 | 18.14 Mn |
| Dec 31, 2022 | 19.10 Mn |
| Sep 30, 2022 | 17.79 Mn |
| Jun 30, 2022 | 16.51 Mn |
| Mar 31, 2022 | 31.68 Mn |
| Dec 31, 2021 | 28.60 Mn |
| Sep 30, 2021 | 28.13 Mn |
API Access
Aligos Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();